All I can say here is that this goes back to a earlier post: The 2 New Hot Words in Healthcare: Algorithms and Whistleblowers In this case we have a bit of both, algorithms created by the scientists, but a requested change by the clinical side of the table? Sounds a bit like the algorithms run...
Posted to
The Medical Quack .... by Barbara Duck
on 11-19-2008
Filed under: Medically Related, Technology, drugs, healthcare, Medical Devices, Prescriptions, FDA, Medications, Whistle Blower, Data, Data Base, Algorithms
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records
Reports of four experimental drugs held up at the FDA emerged in the first two days of this week. “ There’s almost certainly a bit of coincidence at work here, but it also seems to be one more sign of the tough safety climate at the agency these days .” Below are the 4 drugs. No doubt the...
Some of the duties will be outsourced, but under the control of a local office, and portions of this provision will need an act of Congress, so I might guess now’s the time, or after the election maybe to tackle this issue. I would also like to see labels on every product stating the city, origin...
Posted to
The Medical Quack .... by Barbara Duck
on 10-16-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, drugs, FDA, China, Outsourcing, Food products, Congress Pharma
Whistle blowers today seem to be playing a role in the move towards transparency in more ways than one, not to mention the bounty that could be there if a case goes to court and wrongdoing is found to be the case. BD A New Jersey arbitrator ruled that a former Amgen sales rep can proceed with a...
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
Posted to
The Medical Quack .... by Barbara Duck
on 10-06-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Education, FDA, Pharmaceuticals, Pharmacogenomics, DNA Testing
We still need more labeling and the ability for consumers to identify products when recalls are sent out. Look a the Heparin recall that failed, and that was a drug. In a recent post I had some suggestions that can be read here, including disallowing “blind” shipments so it’s not a rat race t find...
Posted to
The Medical Quack .... by Barbara Duck
on 10-03-2008
Filed under: Medically Related, Pharma/FDA News, drugs, FDA, tainted milk, Melamine, Commerce, Transportation Shipping and Receiving, Food products